REFERENCES
1. Tenchov R, Sasso JM, Wang X, Zhou QA. Aging hallmarks and progression and age-related diseases: a landscape view of research advancement. ACS Chem Neurosci. 2024;15:1-30.
2. Li Y, Tian X, Luo J, Bao T, Wang S, Wu X. Molecular mechanisms of aging and anti-aging strategies. Cell Commun Signal. 2024;22:285.
3. Chakravarti D, LaBella KA, DePinho RA. Telomeres: history, health, and hallmarks of aging. Cell. 2021;184:306-22.
4. Rossiello F, Jurk D, Passos JF, d’Adda di Fagagna F. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol. 2022;24:135-47.
5. Di Micco R, Krizhanovsky V, Baker D, d’Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol. 2021;22:75-95.
6. Lima T, Li TY, Mottis A, Auwerx J. Pleiotropic effects of mitochondria in aging. Nat Aging. 2022;2:199-213.
7. Wang K, Liu H, Hu Q, et al. Epigenetic regulation of aging: implications for interventions of aging and diseases. Signal Transduct Target Ther. 2022;7:374.
8. Li Y, Lu J, Cao X, et al. A newly synthesized rhamnoside derivative alleviates alzheimer’s amyloid-β-induced oxidative stress, mitochondrial dysfunction, and cell senescence through upregulating SIRT3. Oxid Med Cell Longev. 2020;2020:7698560.
9. Choo KB, Tai L, Hymavathee KS, et al. Oxidative stress-induced premature senescence in Wharton’s jelly-derived mesenchymal stem cells. Int J Med Sci. 2014;11:1201-7.
10. Dasgupta N, Arnold R, Equey A, Gandhi A, Adams PD. The role of the dynamic epigenetic landscape in senescence: orchestrating SASP expression. NPJ Aging. 2024;10:48.
11. Martínez-Zamudio RI, Stefa A, Nabuco Leva Ferreira Freitas JA, et al. Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars. Cell Genom. 2023;3:100293.
12. González-Gualda E, Baker AG, Fruk L, Muñoz-Espín D. A guide to assessing cellular senescence in vitro and in vivo. FEBS J. 2021;288:56-80.
13. Tuttle CSL, Waaijer MEC, Slee-Valentijn MS, Stijnen T, Westendorp R, Maier AB. Cellular senescence and chronological age in various human tissues: a systematic review and meta-analysis. Aging Cell. 2020;19:e13083.
14. Ajoolabady A, Pratico D, Bahijri S, et al. Hallmarks and mechanisms of cellular senescence in aging and disease. Cell Death Discov. 2025;11:364.
15. Keshavjee B, Lambelet V, Coppola H, et al. Stress-induced premature senescence related to oxidative stress in the developmental programming of nonalcoholic fatty liver disease in a rat model of intrauterine growth restriction. Antioxidants. 2022;11:1695.
16. Larsson LG. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol. 2011;21:367-76.
17. Luo J, Sun T, Liu Z, et al. Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy. Int J Oral Sci. 2025;17:59.
18. Saleh T, Bloukh S, Carpenter VJ, et al. Therapy-induced senescence: an “old” friend becomes the enemy. Cancers. 2020;12:822.
19. Dehkordi SK, Walker J, Sah E, et al. Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathology. Nat Aging. 2021;1:1107-16.
20. Herdy JR, Mertens J, Gage FH. Neuronal senescence may drive brain aging. Science. 2024;384:1404-6.
21. Valentijn FA, Falke LL, Nguyen TQ, Goldschmeding R. Cellular senescence in the aging and diseased kidney. J Cell Commun Signal. 2018;12:69-82.
22. Salerno N, Marino F, Scalise M, et al. Pharmacological clearance of senescent cells improves cardiac remodeling and function after myocardial infarction in female aged mice. Mech Ageing Dev. 2022;208:111740.
23. Li Z, Zhang Z, Ren Y, et al. Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology. 2021;22:165-87.
25. Yang Z, Wen J, Erus G, et al. Brain aging patterns in a large and diverse cohort of 49,482 individuals. Nat Med. 2024;30:3015-26.
26. Ho NCW, Bethlehem RAI, Seidlitz J, et al; Lifespan Brain Chart Consortium. Atypical brain aging and its association with working memory performance in major depressive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9:786-99.
27. Antoniades M, Srinivasan D, Wen J, et al. Relationship between MRI brain-age heterogeneity, cognition, genetics and Alzheimer’s disease neuropathology. EBioMedicine. 2024;109:105399.
28. Ya J, Bayraktutan U. Senolytics and senomorphics targeting p38MAPK/NF-κB pathway protect endothelial cells from oxidative stress-mediated premature senescence. Cells. 2024;13:1292.
29. Rezagholizadeh N, Datta G, Hasler WA, et al. SLC38A9 is directly involved in Tat-induced endolysosome dysfunction and senescence in astrocytes. Life Sci Alliance. 2025;8:e202503231.
30. Gross PS, Durán-Laforet V, Ho LT, et al. Senescent-like microglia limit remyelination through the senescence associated secretory phenotype. Nat Commun. 2025;16:2283.
31. Luo N, Zhu W, Li X, et al. Defective autophagy of pericytes enhances radiation-induced senescence promoting radiation brain injury. Neuro Oncol. 2024;26:2288-304.
32. Budamagunta V, Kumar A, Rani A, et al. Effect of peripheral cellular senescence on brain aging and cognitive decline. Aging Cell. 2023;22:e13817.
33. Zhang W, Sun HS, Wang X, Dumont AS, Liu Q. Cellular senescence, DNA damage, and neuroinflammation in the aging brain. Trends Neurosci. 2024;47:461-74.
34. Cuanalo-Contreras K, Schulz J, Mukherjee A, Park KW, Armijo E, Soto C. Extensive accumulation of misfolded protein aggregates during natural aging and senescence. Front Aging Neurosci. 2022;14:1090109.
35. Herdy JR, Traxler L, Agarwal RK, et al. Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease. Cell Stem Cell. 2022;29:1637-52.e6.
36. Jiang SY, Tian T, Yao H, et al. The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson’s disease via LCN2-dependent astrocyte senescence. Cell Death Differ. 2023;30:2280-92.
37. Jurk D, Wang C, Miwa S, et al. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell. 2012;11:996-1004.
38. :2024.01.20.576299. Donovan LJ, Brewer CL, Bond SF, et al. Aging and injury drive neuronal senescence in the dorsal root ganglia. bioRxiv 2024; bioRxiv:2024.01.20.576299.
39. Choi I, Wang M, Yoo S, et al. Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Nat Cell Biol. 2023;25:963-74.
40. Du T, Li G, Zong Q, Luo H, Pan Y, Ma K. Nuclear alpha-synuclein accelerates cell senescence and neurodegeneration. Immun Ageing. 2024;21:47.
41. Chemparathy DT, Ray S, Ochs C, et al. Neuropathogenic role of astrocyte-derived extracellular vesicles in HIV-associated neurocognitive disorders. J Extracell Vesicles. 2024;13:e12439.
42. van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64:676-705.
43. Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8:727.
44. Odegaard KE, Chand S, Wheeler S, et al. Role of extracellular vesicles in substance abuse and HIV-related neurological pathologies. Int J Mol Sci. 2020;21:6765.
45. Scuteri A, Donzelli E. Dual role of extracellular vesicles in neurodegenerative diseases. World J Stem Cells. 2024;16:1002-11.
46. Schnatz A, Müller C, Brahmer A, Krämer-Albers EM. Extracellular vesicles in neural cell interaction and CNS homeostasis. FASEB Bioadv. 2021;3:577-92.
47. Wallis R, Mizen H, Bishop CL. The bright and dark side of extracellular vesicles in the senescence-associated secretory phenotype. Mech Ageing Dev. 2020;189:111263.
48. Guix FX, Capitán AM, Casadomé-Perales Á, et al. Increased exosome secretion in neurons aging in vitro by NPC1-mediated endosomal cholesterol buildup. Life Sci Alliance. 2021;4:e202101055.
49. Soukup J, Moško T, Kereïche S, Holada K. Large extracellular vesicles transfer more prions and infect cell culture better than small extracellular vesicles. Biochem Biophys Res Commun. 2023;687:149208.
50. Jeon I, Cicchetti F, Cisbani G, et al. Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta Neuropathol. 2016;132:577-92.
51. Neueder A, Nitzschner P, Wagner R, et al. Huntington disease alters the actionable information in plasma extracellular vesicles. Clin Transl Med. 2024;14:e1525.
52. You B, Yang Y, Zhou Z, et al. Extracellular vesicles: a new frontier for cardiac repair. Pharmaceutics. 2022;14:1848.
53. Boyer E, Deltenre L, Dourte M, et al. Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s disease patients and cognitively normal individuals. Alzheimers Res Ther. 2024;16:141.
54. Fowler SL, Behr TS, Turkes E, et al. Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease. Nat Neurosci. 2025;28:40-8.
55. Sattarov R, Havers M, Orbjörn C, et al. Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study. Sci Rep. 2024;14:25419.
56. Gilboa T, Ter-Ovanesyan D, Wang SC, et al. Measurement of α-synuclein as protein cargo in plasma extracellular vesicles. Proc Natl Acad Sci U S A. 2024;121:e2408949121.
57. Chatterjee M, Özdemir S, Fritz C, et al. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med. 2024;30:1771-83.
58. Rufino-Ramos D, Albuquerque PR, Leandro K, et al. Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3. Mol Ther. 2023;31:1275-92.
59. Xiao X, Xu M, Yu H, et al. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a/Src. Signal Transduct Target Ther. 2021;6:354.
60. Mas-Bargues C, Sanz-Ros J, Román-Domínguez A, et al. Extracellular vesicles from healthy cells improves cell function and stemness in premature senescent stem cells by miR-302b and HIF-1α activation. Biomolecules. 2020;10:957.
61. Larrow DR, Cohen MS. Endoscopic approach for tympanostomy tube insertion in patients with trisomy 21. Otol Neurotol. 2025;46:e206.
62. Dave KM, Venna VR, Rao KS, et al. Mitochondria-containing extracellular vesicles from mouse vs. human brain endothelial cells for ischemic stroke therapy. J Control Release. 2024;373:803-22.
63. Liu J, Peng L, He L, et al. Induced mesenchymal stem cells-small extracellular vesicles alleviate post-stroke cognitive impairment by rejuvenating senescence of neural stem cells. J Mol Neurosci. 2024;74:29.
64. Yu L, Wen H, Liu C, et al. Embryonic stem cell-derived extracellular vesicles rejuvenate senescent cells and antagonize aging in mice. Bioact Mater. 2023;29:85-97.
65. Chun C, Smith AST, Kim H, et al. Astrocyte-derived extracellular vesicles enhance the survival and electrophysiological function of human cortical neurons in vitro. Biomaterials. 2021;271:120700.
66. Zhang X, Liu T, Hou X, et al. Exosomes secreted by mesenchymal stem cells delay brain aging by upregulating SIRT1 expression. Sci Rep. 2023;13:13213.
67. Li Q, Niu X, Yi Y, et al. Inducible pluripotent stem cell-derived small extracellular vesicles rejuvenate senescent blood-brain barrier to protect against ischemic stroke in aged mice. ACS Nano. 2023;17:775-89.
69. Head D, Rodrigue KM, Kennedy KM, Raz N. Neuroanatomical and cognitive mediators of age-related differences in episodic memory. Neuropsychology. 2008;22:491-507.
70. Mungas D, Harvey D, Reed BR, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005;65:565-71.
71. Fjell AM, Walhovd KB. Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci. 2010;21:187-221.
72. Rajah MN, Kromas M, Han JE, Pruessner JC. Group differences in anterior hippocampal volume and in the retrieval of spatial and temporal context memory in healthy young versus older adults. Neuropsychologia. 2010;48:4020-30.
73. Bethlehem RAI, Seidlitz J, White SR, et al; 3R-BRAIN, AIBL, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Repository Without Borders Investigators, CALM Team, Cam-CAN, CCNP, COBRE, cVEDA, ENIGMA Developmental Brain Age Working Group, Developing Human Connectome Project, FinnBrain, Harvard Aging Brain Study, IMAGEN, KNE96, Mayo Clinic Study of Aging, NSPN, POND, PREVENT-AD Research Group, VETSA. Brain charts for the human lifespan. Nature. 2022;604:525-33.
74. Bennett IJ, Madden DJ. Disconnected aging: cerebral white matter integrity and age-related differences in cognition. Neuroscience. 2014;276:187-205.
75. Hao Y, Yu B, Qin M, et al. Extracellular vesicles from antler blastema progenitor cells reverse bone loss and mitigate aging-related phenotypes in mice and macaques. Nat Aging. 2025;5:1790-809.
76. Chen Q, Liu J, Sawada T, Wei C, Wu S, Han F. Possible role of EphA4 and VEGFR2 interactions in neural stem and progenitor cell differentiation. Exp Ther Med. 2020;19:1789-96.
77. Yokote H, Fujita K, Jing X, et al. Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains. Proc Natl Acad Sci U S A. 2005;102:18866-71.
78. Ghosh S, Roy R, Mukherjee N, et al. EphA4 targeting peptide-conjugated extracellular vesicles rejuvenates adult neural stem cells and exerts therapeutic benefits in aging rats. ACS Chem Neurosci. 2024;15:3482-95.
79. Jankovic V, Ciarrocchi A, Boccuni P, DeBlasio T, Benezra R, Nimer SD. Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc Natl Acad Sci U S A. 2007;104:1260-5.
80. Harischandra DS, Rokad D, Ghaisas S, et al. Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson’s disease. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165533.
81. Lee S, Choi K, Ahn H, Song K, Choe J, Lee I. TuJ1 (class III beta-tubulin) expression suggests dynamic redistribution of follicular dendritic cells in lymphoid tissue. Eur J Cell Biol. 2005;84:453-9.
82. Park D, Xiang AP, Mao FF, et al. Nestin is required for the proper self-renewal of neural stem cells. Stem Cells. 2010;28:2162-71.
83. Winship IR, Murphy TH. Remapping the somatosensory cortex after stroke: insight from imaging the synapse to network. Neuroscientist. 2009;15:507-24.
84. Singh AD, Kumar M, Swathi BH, Bhargavi P, Godbole A, Khushu S. Age-related cortical changes and cognitive performance in healthy adults. Brain Cogn. 2025;187:106306.
85. Floel A, Cohen LG. Recovery of function in humans: cortical stimulation and pharmacological treatments after stroke. Neurobiol Dis. 2010;37:243-51.
86. Festa LK, Grinspan JB, Jordan-Sciutto KL. White matter injury across neurodegenerative disease. Trends Neurosci. 2024;47:47-57.
87. Zhou Y, Bhatt H, Mojica CA, et al. Mesenchymal-derived extracellular vesicles enhance microglia-mediated synapse remodeling after cortical injury in aging Rhesus monkeys. J Neuroinflammation. 2023;20:201.
88. Fraser DA, Pisalyaput K, Tenner AJ. C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J Neurochem. 2010;112:733-43.
89. Go V, Sarikaya D, Zhou Y, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells enhance myelin maintenance after cortical injury in aged rhesus monkeys. Exp Neurol. 2021;337:113540.
90. Medalla M, Chang W, Calderazzo SM, et al. Treatment with mesenchymal-derived extracellular vesicles reduces injury-related pathology in pyramidal neurons of monkey perilesional ventral premotor cortex. J Neurosci. 2020;40:3385-407.
91. Go V, Bowley BGE, Pessina MA, et al. Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys. Geroscience. 2020;42:1-17.
92. Chang J, Li Y, Shan X, et al. Neural stem cells promote neuroplasticity: a promising therapeutic strategy for the treatment of Alzheimer’s disease. Neural Regen Res. 2024;19:619-28.
93. Niu X, Xia Y, Luo L, et al. iPSC-sEVs alleviate microglia senescence to protect against ischemic stroke in aged mice. Mater Today Bio. 2023;19:100600.
94. Kodali M, Madhu LN, Reger RL, et al. A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling. Front Mol Neurosci. 2023;16:1185883.
95. Lee Y, Lee J, Kim J, et al. hESC-derived extracellular vesicles enriched with MFGE-8 and the GSH redox system act as senotherapeutics for neural stem cells in ischemic stroke. Free Radic Biol Med. 2025;229:333-49.
96. Natale F, Leone L, Rinaudo M, et al. Neural stem cell-derived extracellular vesicles counteract insulin resistance-induced senescence of neurogenic niche. Stem Cells. 2022;40:318-31.
97. Rao S, Madhu LN, Babu RS, et al. Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation. Stem Cell Res Ther. 2025;16:191.
98. Deng S, Xie H, Xie B. Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases. Stem Cell Res Ther. 2025;16:167.
99. Hu G, Xia Y, Chen B, et al. ESC-sEVs rejuvenate aging hippocampal NSCs by transferring SMADs to regulate the MYT1-Egln3-Sirt1 axis. Mol Ther. 2021;29:103-20.
100. Sahay A, Scobie KN, Hill AS, et al. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature. 2011;472:466-70.
101. Babcock KR, Page JS, Fallon JR, Webb AE. Adult hippocampal neurogenesis in aging and Alzheimer’s disease. Stem Cell Reports. 2021;16:681-93.
102. Wang SN, Xu TY, Li WL, Miao CY. Targeting nicotinamide phosphoribosyltransferase as a potential therapeutic strategy to restore adult neurogenesis. CNS Neurosci Ther. 2016;22:431-9.
103. Leu T, Fandrey J, Schreiber T. (H)IF applicable: promotion of neurogenesis by induced HIF-2 signalling after ischaemia. Pflugers Arch. 2021;473:1287-99.
104. Mormone E, Iorio EL, Abate L, Rodolfo C. Sirtuins and redox signaling interplay in neurogenesis, neurodegenerative diseases, and neural cell reprogramming. Front Neurosci. 2023;17:1073689.
105. Oh H, Kwak JS, Yang S, et al. Reciprocal regulation by hypoxia-inducible factor-2α and the NAMPT-NAD+-SIRT axis in articular chondrocytes is involved in osteoarthritis. Osteoarthritis Cartilage. 2015;23:2288-96.
106. Guo J, Huang X, Dou L, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7:391.
107. Liu Y, Tan Y, Zhang Z, Yi M, Zhu L, Peng W. The interaction between ageing and Alzheimer’s disease: insights from the hallmarks of ageing. Transl Neurodegener. 2024;13:7.
108. Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement. 2018;4:575-90.
109. Pajares M, I Rojo A, Manda G, Boscá L, Cuadrado A. Inflammation in Parkinson’s disease: mechanisms and therapeutic implications. Cells. 2020;9:1687.
110. Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7:47.
111. Testo AA, Roundy G, Dumas JA. Cognitive decline in Alzheimer’s disease. Curr Top Behav Neurosci. 2025;69:181-95.
112. Yeapuri P, Machhi J, Foster EG, et al. Amyloid precursor protein and presenilin-1 knock-in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss. Alzheimers Dement. 2025;21:e70084.
113. Safiri S, Ghaffari Jolfayi A, Fazlollahi A, et al. Alzheimer’s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Front Med. 2024;11:1474043.
114. Musi N, Valentine JM, Sickora KR, et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell. 2018;17:e12840.
116. Koh SH, Choi SH, Jeong JH, et al. Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease. Aging. 2020;12:4407-23.
117. Zhang P, Kishimoto Y, Grammatikakis I, et al. Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model. Nat Neurosci. 2019;22:719-28.
118. Gonzales MM, Garbarino VR, Marques Zilli E, et al. Senolytic therapy to modulate the progression of Alzheimer’s disease (SToMP-AD): a pilot clinical trial. J Prev Alzheimers Dis. 2022;9:22-9.
119. Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018;562:578-82.
120. Ogrodnik M, Evans SA, Fielder E, et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell. 2021;20:e13296.
121. Xu F, Wu Y, Yang Q, et al. Engineered extracellular vesicles with SHP2 high expression promote mitophagy for Alzheimer’s disease treatment. Adv Mater. 2022;34:e2207107.
122. Gao G, Li C, Ma Y, et al. Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model. Signal Transduct Target Ther. 2023;8:228.
123. Apodaca LA, Baddour AAD, Garcia C Jr, et al. Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer’s disease. Alzheimers Res Ther. 2021;13:57.
124. Madhu LN, Kodali M, Upadhya R, et al. Extracellular vesicles from human-induced pluripotent stem cell-derived neural stem cells alleviate proinflammatory cascades within disease-associated microglia in Alzheimer’s disease. J Extracell Vesicles. 2024;13:e12519.
125. Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson’s disease. Lancet. 2024;403:293-304.
126. Krawczuk D, Groblewska M, Mroczko J, Winkel I, Mroczko B. The role of α-synuclein in etiology of neurodegenerative diseases. Int J Mol Sci. 2024;25:9197.
127. Pereira SL, Grossmann D, Delcambre S, Hermann A, Grünewald A. Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Curr Opin Neurobiol. 2023;80:102720.
128. Björkblom B, Adilbayeva A, Maple-Grødem J, et al. Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity. J Biol Chem. 2013;288:22809-20.
129. Liu Y, Song Y, Zhu X. MicroRNA-181a regulates apoptosis and autophagy process in Parkinson’s disease by inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways. Med Sci Monit. 2017;23:1597-606.
130. Ding H, Huang Z, Chen M, et al. Identification of a panel of five serum miRNAs as a biomarker for Parkinson’s disease. Parkinsonism Relat Disord. 2016;22:68-73.
131. Ma J, Shi X, Li M, et al. MicroRNA-181a-2-3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson’s disease by inhibiting EGR1 and NOX4. Cell Death Discov. 2022;8:33.
132. Chen HX, Liang FC, Gu P, et al. Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. Cell Death Dis. 2020;11:288.
133. Ramalingam M, Jang S, Hwang J, Cho HH, Kim BC, Jeong HS. Neural-induced human adipose tissue-derived stem cell secretome exerts neuroprotection against rotenone-induced Parkinson’s disease in rats. Stem Cell Res Ther. 2025;16:193.
134. Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213-28.
135. Chen R, Powell JS, Shufesky WJ, et al. Transplants foster B cell alloimmunity by relaying extracellular vesicles to follicular dendritic cells. Cell Rep. 2025;44:115832.
136. Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.
137. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.
138. Ding L, Guo Q, Ren Y, et al. Construction of [89Zr]Zr-labeled human umbilical cord mesenchymal stem cell-derived extracellular vesicles for noninvasive detection of tumors. ACS Appl Mater Interfaces. 2025;17:30589-99.
139. Chung YH, Ho YP, Farn SS, et al. In vivo SPECT imaging of Tc-99m radiolabeled exosomes from human umbilical-cord derived mesenchymal stem cells in small animals. Biomed J. 2024;47:100721.
140. Elsharkasy OM, Nordin JZ, Hagey DW, et al. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020;159:332-43.
141. Walker S, Busatto S, Pham A, et al. Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics. 2019;9:8001-17.
142. Barilani M, Peli V, Manzini P, et al. Extracellular vesicles from human induced pluripotent stem cells exhibit a unique microRNA and circRNA signature. Int J Biol Sci. 2024;20:6255-78.
143. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
